Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.

Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S.

Psychiatry Res. 2009 Sep 30;169(2):132-8. doi: 10.1016/j.psychres.2009.04.004. Epub 2009 Aug 26.

PMID:
19709754
3.

Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?

Montgomery SA, Möller HJ.

Int Clin Psychopharmacol. 2009 May;24(3):111-8. doi: 10.1097/YIC.0b013e32832a8eb2. Review.

PMID:
19357527
4.
5.

[Severe forms of depression: the efficacy of escitalopram].

Spadone C.

Encephale. 2009 Apr;35(2):152-9. doi: 10.1016/j.encep.2008.09.008. Epub 2009 Mar 31. Review. French.

PMID:
19393384
6.

Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, Moore CG, Morgan L, Lohr KN.

Ann Intern Med. 2008 Nov 18;149(10):734-50. Review.

PMID:
19017592
7.

Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.

Pae CU, Lim HK, Han C, Patkar AA, Steffens DC, Masand PS, Lee C.

Expert Rev Neurother. 2007 Oct;7(10):1251-63. Review.

PMID:
17939764
8.

[Escitalopram versus citalopram in true depression. Review of studies do not support clinically relevant differences of the effect].

Schwan S, Hallberg P.

Lakartidningen. 2009 Mar 18-24;106(12):858-61. Review. Swedish. No abstract available.

PMID:
19452787
9.

Escitalopram: efficacy and tolerability in the treatment of depression.

Baldwin DS.

Hosp Med. 2002 Nov;63(11):668-71. Review.

PMID:
12474611
10.

Why isn't bupropion the most frequently prescribed antidepressant?

Zimmerman M, Posternak MA, Attiullah N, Friedman M, Boland RJ, Baymiller S, Berlowitz SL, Rahman S, Uy KK, Singer S, Chelminski I.

J Clin Psychiatry. 2005 May;66(5):603-10. Review.

PMID:
15889947
11.

Escitalopram for the treatment of major depression and anxiety disorders.

Höschl C, Svestka J.

Expert Rev Neurother. 2008 Apr;8(4):537-52. doi: 10.1586/14737175.8.4.537. Review.

PMID:
18416657
12.

The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.

Bareggi SR, Mundo E, Dell'Osso B, Altamura AC.

Expert Opin Drug Metab Toxicol. 2007 Oct;3(5):741-53. Review.

PMID:
17916059
13.

Symptoms of fatigue and sleepiness in major depressive disorder.

Baldwin DS, Papakostas GI.

J Clin Psychiatry. 2006;67 Suppl 6:9-15. Review.

14.

Electroencephalography-derived biomarkers of antidepressant response.

Iosifescu DV.

Harv Rev Psychiatry. 2011 May-Jun;19(3):144-54. doi: 10.3109/10673229.2011.586549. Review.

PMID:
21631160
15.

The efficacy and tolerability of bupropion in the treatment of major depressive disorder.

Moreira R.

Clin Drug Investig. 2011 Oct 19;31 Suppl 1:5-17. doi: 10.2165/1159616-S0-000000000-00000. Review.

PMID:
22015858
16.

[Escitalopram and citalopram: the unexpected role of the R-enantiomer].

Jacquot C, David DJ, Gardier AM, Sánchez C.

Encephale. 2007 Mar-Apr;33(2):179-87. Review. French.

PMID:
17675913
17.

Spotlight on bupropion in major depressive disorder.

Dhillon S, Yang LP, Curran MP.

CNS Drugs. 2008;22(7):613-7. Review.

PMID:
18547129
18.

Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?

Clayton AH.

Expert Opin Pharmacother. 2007 Mar;8(4):457-66. Review.

PMID:
17309340
19.

Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram.

Kasper S, Sacher J, Klein N, Mossaheb N, Attarbaschi-Steiner T, Lanzenberger R, Spindelegger C, Asenbaum S, Holik A, Dudczak R.

Int Clin Psychopharmacol. 2009 May;24(3):119-25. doi: 10.1097/YIC.0b013e32832a8ec8. Review.

PMID:
19367152
20.

Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder.

Papakostas GI.

J Clin Psychiatry. 2009;70 Suppl 6:16-25. doi: 10.4088/JCP.8133su1c.03. Review.

Supplemental Content

Support Center